Stem cell controversy to stall European tissue and cell therapy rules

Article Abstract:

The different views among European Union (EU) member states on human embryonic stem cell research might stall the creation of a new regulatory framework to address the sale and marketing of cell therapies and tissue-engineered products. The politically sensitive issue of embryonic stem (ES) cell research might delay the passage of the legislation, which is expected to be debated by the committee of the European Parliament on May 11, 2006.

Government domestic functions, Usage, Political aspects, Science and technology policy, European Union, Cellular therapy, Cell therapy, Stem cell research

---

Flies in the soup - European GM labeling legislation

Article Abstract:

The European Unions (EU) labeling legislation, which will soon be applicable to all foods and ingredients produced from genetically modified (GM) organisms (GMOs), will affect the food industry unfavorably. The new rules defined by the EU are not clear, thus highlighting the need for the development of a set of rules that will be applicable in the current as well as the future scenario.

FOOD AND KINDRED PRODUCTS, Coated and Laminated Paper Manufacturing, Pressure Sensitive Products, Food industry, Labeling, Labels, Food and beverage production/distribution software

---

Fractured European market undermines biosimilar launches

Article Abstract:

Two similar versions of the world's biggest-selling biotech drug, erythropoietin (EPO), are set to be launched in the European biosimilars market. The issues relating to the growth of the biosimilars market and the sale of biosimilar products are discussed.

Marketing procedures, Management dynamics, Management, Marketing, Company marketing practices, Company business management, Erythropoietin, European Agency for the Evaluation of Medicinal Products

Similar abstracts:

• Abstracts: Sega shows the future. Sega Europe's triple threat is released. Reflex shows three new games at ATEI
• Abstracts: The business case. PwC moves to limit damage from Japan crisis
• Abstracts: Fees paid to audit firms, accrual choices, and corporate governance. Accountability demands and the auditor's evidence search strrategy; the influence of reviewer preferences and the nature of the response (belief vs. action)
• Abstracts: Executive turnover in UK firms: the impact of Cadbury. What has the invisible hand achieved? A unified approach to the measurement of international accounting harmony
• Abstracts: US to safeguard 'dual-use' biology research. Bayh-Dole: If we knew then what we know now. Syngenta's gaff embarrasses industry and White House

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.